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Abstract
Background: It is well known that the information requirements necessary to safely treat children with therapeutic
medications cannot be met with the same approaches used in adults. Over a 1-year period, Duke University
Hospital engaged in the challenging task of enhancing an established computerized provider order entry (CPOE)
system to address the unique medication dosing needs of pediatric patients.
Methods: An advanced dosing model (ADM) was designed to interact with our existing CPOE application to
provide decision support enabling complex pediatric dose calculations based on chronological age, gestational
age, weight, care area in the hospital, indication, and level of renal impairment. Given that weight is a critical
component of medication dosing that may change over time, alerting logic was added to guard against erroneous
entry or outdated weight information.
Results: Pediatric CPOE was deployed in a staggered fashion across 6 care areas over a 14-month period.
Safeguards to prevent miskeyed values became important in allowing providers the flexibility to override the ADM
logic if desired. Methods to guard against over- and under-dosing were added. The modular nature of our model
allows us to easily add new dosing scenarios for specialized populations as the pediatric population and formulary
change over time.
Conclusions: The medical needs of pediatric patients vary greatly from those of adults, and the information
systems that support those needs require tailored approaches to design and implementation. When a single CPOE
system is used for both adults and pediatrics, safeguards such as redirection and suppression must be used to
protect children from inappropriate adult medication dosing content. Unlike other pediatric dosing systems, our
model provides active dosing assistance and dosing process management, not just static dosing advice.
Background
Medication management in children poses distinctive
challenges [1,2], as pediatricians need to calculate doses
based on weight, age, gestational age, and indication,
which may increase the risk of mathematical errors (such
as the serious and common 10-fold overdose) [3]. Pedia-
tric pharmacists often work with adult formulations and
must manually compound suspensions for use in pediatric
patients. Most importantly, childhood is an inherently
dynamic period during which children experience rapidly
changing weights and physiologic fluctuations that place
them at high risk for incorrect dosing. Given the limited
physiologic reserve of pediatric patients, small miscalcula-
tions caused by technical glitches or improper system
design can cause significant morbidity and mortality [2,4].
Some of these challenges can be addressed using compu-
terized provider order entry (CPOE) systems, and the
American Academy of Pediatrics policy statement on the
prevention of medication errors strongly recommends the
use of “computerized systems” whenever feasible [5].
Research on the epidemiology of adverse drug events
(ADEs) in pediatric inpatients reveals that most ADEs
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any medium, provided the original work is properly cited.originate at the drug ordering stage, with the smallest and
most critically ill patients at highest risk [6-9]. In adults,
CPOE has been shown to decrease the incidence of medi-
cation errors by 55% [10], and CPOE with advanced clinical
decision support can decrease error rates by 83% [5,11].
Several studies of pediatric inpatients have demonstrated
decreases in medication errors after the implementation of
CPOE [8,12,13], and 1 study of pediatric intensive care unit
(ICU) patients found a 95% reduction in medication errors
and a 40% reduction in potential ADEs following CPOE
implementation [14]. However, few studies have shown
improvements in post-CPOE implementation outcome
measures such as actual (not potential) ADEs, even after
meta-analysis of multiple studies [15] or an advanced time-
series analysis is performed [16,17]. Furthermore, the land-
mark study in 2005 by Han reporting an unexpected
increase in ICU pediatric mortality related to a pediatric
CPOE implementation [18] sparked a nationwide dialogue
about the relationship between technology and patient
safety. Del Beccaro et al. provided another perspective on
this topic by similarly evaluating the same CPOE product
in a separate tertiary care facility [19]. They found no mor-
tality increase in critical care areas, and attributed this to a
more careful implementation process and the design of
ICU-specific order sets. Recently, another group demon-
strated a reduction of mortality after implementing a
vended but locally modified product at an academic chil-
dren’s hospital [20]. In this time of increased awareness, it
is essential that pediatric centers share their experiences to
improve large-scale pediatric deployment of CPOE.
Unfortunately, there is significant variability in the level of
pediatric-specific medication dosing functionality built into
today’s CPOE structures. An institution wishing to imple-
ment pediatric CPOE often faces a difficult choice between
replacing its legacy system with a dedicated pediatric CPOE
application [21-23] versus enhancing the existing function-
ality of an adult-focused CPOE application. At Duke Uni-
versity Hospital (DUH), we chose the latter option, working
with our CPOE vendor (Horizon Expert Orders, McKesson
Corporation, San Francisco) to adapt our existing, adult-
focused system to provide pediatric CPOE. In doing so, we
created the “Advanced Dosing Model” (ADM) within the
CPOE application to address the unique dosing needs of
children. The ADM uses broad clinical decision support to
incorporate many criteria into medication dosing such as
weight, age, indication, and safety alerts that are built into
clinical content. We feel the details of this novel model are
sufficiently complex to warrant its own report distinct from
other elements of pediatric CPOE.
Methods
Setting and implementation period
Duke Children’s Hospital (DCH) is a tertiary care facility
within DUH that comprises 7 inpatient pediatric service
locations: 2 general care medical wards, a pediatric
i n t e n s i v ec a r eu n i t( P I C U ) ,an e o n a t a li n t e n s i v ec a r e
unit (NICU), a bone marrow transplant (BMT) unit, a
pediatric cardiac ICU, and a transitional care (i.e., step-
down) unit. DCH averages 7000 pediatric admissions
per year across 187 inpatient beds, approximately 50%
of which are located in critical care wards. DCH
employs approximately 197 attending physicians and
50 pediatric residents across 20 clinical service areas.
Table 1 details release of the CPOE application, which
included the ADM functionality described in this report,
in order of deployment over a 14-month period across
pediatric units (Table 1).
CPOE architecture at Duke University Hospital
At DUH, the Horizon Expert Orders (HEO) CPOE sys-
tem (McKesson Corporation, San Francisco, CA) is a
comprehensive order management system that spans
medical disciplines and offers real-time decision support
and guidance for order entry. This product was
deployed on all DUH adult floors by April, 2006. Provi-
ders interact with a Java-based desktop client (Java ver-
sion 1.42.09) that queries an Oracle 10 database (Oracle
Corporation, Redwood Shores, CA) holding both the
clinical content tables (e.g., orderables, order sets, and
clinical decision support information) and patient infor-
mation tables (e.g., patient identity, care area, diagnoses,
existing orders). New provider choices made through
the CPOE client are saved to the patient information
table and executed as HL7 messages to other hospital
information technology (IT) applications that fulfill the
orders.
Medication challenges at Duke Children’s Hospital
DCH’s pre-implementation medication vulnerabilities
were similar to those described by other tertiary care
institutions and have been reported previously in an
analysis of both voluntarily reported events and ADEs
detected by computerized surveillance [24]. Briefly,
DCH sees approximately 18.0 medication-related safety
Table 1 Deployment of pediatric CPOE at Duke Children’s
Hospital
Care area CPOE release date Current patient beds*
General care (2 units) 1/17/2007 61
Transitional care 1/17/2007 16
PICU 4/24/2007 16
Bone marrow transplant 8/28/2007 16
NICU 3/10/2008 65
Pediatric cardiac ICU
† 1/06/2009 13
*Number of beds in service as of 1/29/2010.
†New pediatric location introduced to DCH after full CPOE deployment on
3/10/2008.
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reporting. Of these, approximately 10.9% result in some
level of patient harm. Computerized surveillance, a com-
plementary incident detection method that behaves as
an automated trigger tool, found 1.6 ADEs per 1000
patient days. As expected, event density is higher in cri-
tical care units than in general care areas. The most
common problem areas are failures in the medication
use process such as incorrect drug dose or rate followed
by drug omissions. Antibiotics in particular were a drug
class identified for enhanced surveillance targeting. We
reported that the safety profile of pediatrics was distinct
from that of adults, underscoring the importance of
pediatric-specific clinical content for dosing guidance
[25].
Needs assessment
Because DCH serves challenging, critically ill pediatric
patients, the deployment of CPOE in this environment
was deferred until the end of the adult CPOE imple-
mentation plan. A needs assessment was performed by a
multidisciplinary clinical advisory workgroup of physi-
cians, nurses, pharmacists, and safety directors to define
the features and work flow requirements for a pediatric
CPOE product deployed to DCH. These individuals
made broad decisions that would affect clinician work
flow, and their input was critical to ensure operational
acceptance. It was immediately recognized that a pedia-
tric CPOE application would require high flexibility to
approach the wide variety of nuanced, sometimes novel,
pediatric therapies in place at DCH. Given that the
existing CPOE system provides adult dosing guidance
via a specific set of clinical content tables, it was recog-
nized that the needs of pediatric dosing could be satis-
fied through adding an additional set of tables for that
population while maintaining the existing adult-based
infrastructure. As a result, the most efficient plan was to
partner with McKesson to enhance the adult product
for pediatric usage instead of implementing a new,
vended solution. McKesson and DUH agreed to a joint
development project to incorporate clinical content
from the pediatric WizOrder tool [26], acquired by
McKesson from Vanderbilt University Medical Center,
into the HEO commercial product. The clinical advisory
committee continued to meet weekly for 6 months prior
to system release to discuss clinical issues, understand
technological implications of the application, and act as
liaisons to technical developers at McKesson for all
areas of pediatric CPOE design.
Functional design of the pediatric Advanced Dosing
Model (ADM)
By the broadest definition, the ADM as it relates to
HEO is a combination of clinical content tables and
decision tree logic layered on top of the existing adult
CPOE application to provide extensive, content-driven,
drug-by-drug clinical decision support for pediatric
medication dosing. Based on the clinical advisory com-
mittee’sr e c o m m e n d a t i o n s ,a nA D Mf o c u sg r o u pw a s
convened to specifically address its functional require-
ments and design details. This group included 15 pedia-
tric pharmacists charged with defining the detailed
patient-specific criteria that shape the dosing scenarios
for each drug. To facilitate this, a temporary web appli-
cation and supporting database was built to store their
design decisions and manage the pertinent clinical
content.
Instead of simply facilitating weight-based calculations
familiar to pediatric dosing, we sought to create a broad
clinical decision support system that incorporates up to
6 patient-specific parameters (Table 2) and safety alerts.
The major functional design decisions from both the
clinical advisory committee and ADM focus group were:
￿ The ADM should provide clinical guidance and
targeted medication dosing recommendations based
on 1 or more patient-centric criteria at the time of
order entry.
￿ The clinical decision support information sur-
rounding medication dosing that populates CPOE
clinical content tables should address the diverse
needs of general and specialized pediatric popula-
tions. In this way, these tables can act as a centra-
lized body of complex yet agreed-upon clinical
dosing standards for the hospital.
￿ The ADM processing logic should be designed to
proactively alert clinicians when changes in patient
criteria might warrant dosing changes based on the
configured clinical knowledge base.
When a single CPOE system is used for both children
and adults, the system must differentiate between the
Table 2 Pediatric patient parameters reasoned over by
the Advanced Dosing Model logic
Criterion Definition
Indication A condition that makes a particular medication dose
advisable
Care area Physical location of patient within DCH, which is used
to infer care intensity
Chronological
age
Age of patient in years, months, and days since date
of birth
Post-
conceptual age
Age of patient in years, months, and days since
clinician-estimated date of conception
Dosing weight A user-defined weight that will be used to dose
medications; this may not reflect a patient’s current
actual weight
Renal
impairment
Qualitative assessment of renal impairment by the
ordering provider; i.e., “impaired” or “not impaired”
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that applies only to children. This is especially important
on surgical services where residents care for both adults
and children, or in cases of off-service placement where
children are cared for on adult floors due to space lim-
itations or unusual practice patterns. After careful multi-
d i s c i p l i n a r ya n a l y s i s ,t h ea d v i s o r yg r o u pu s e da g es o l e l y
to define a pediatric patient (< 14 years of age or <18
years and <45 kg [99 lbs]) in order to capture indivi-
duals regardless of location.
Development of pediatric clinical content
To build pediatric clinical content as part of the ADM,
unique patient scenarios were identified that may drive
a dosing end point for a specific medication. Each
unique dosing scenario is termed a medication “dosing
region"; that is, the constellation of clinical characteris-
tics that stipulates a specific pediatric dosage for a given
drug. A drug that has a variety of clinical usage scenar-
ios therefore has multiple dosing regions. A dosing
region can be based on as few or as many criteria as are
needed to achieve the specificity required. Similarly, a
medication may have numerous associated dosing
regions depending on the complexity of the dosing per-
mutations given the patient-specific criteria. For
example, Table 3 displays dosing regions built for sev-
eral ampicillin indications based on different patient
scenarios.
Creating the formulary of adult drugs in the initial
launch of adult CPOE was very labor-intensive even
when each drug could contain only 1 set of dosing
options. We sought to limit initial development to only
high-use medications as well as to those that have ser-
ious safety concerns. To identify this subset, we pulled
information regarding drug utilization for a 1-year per-
iod from the pharmacy medication management pro-
gram. A list including the top 100 most commonly
prescribed drugs on pediatric floors was sent to the
pediatric pharmacist workgroup. Collective clinical
review reduced this list by removing orderables that
already had existing clinical decision support through
elaborate advisor interfaces (i.e., insulin prescribing or
intravenous fluids). Additionally, chemotherapy is not
currently handled within CPOE at Duke University Hos-
pital as it is paper-based and protocol-driven. The work-
group then added medications to this list, regardless of
usage frequency, if any of the following conditions were
met: a) the drug had high risk of a severe prescribing
error; b) the drug had high seasonal usage; or c) the
drug appeared on care area “pocket cards.” Nurses
Table 3 Dosing regions for several ampicillin indications
Indication Care area Age Weight (kg) Dose
Bone marrow transplant ≤29 days < 8 100 mg/kg/dose IV q8h
≥8 100 mg/kg/dose IV q8 h up to a max single dose of 1 g
Meningitis NICU, transitional care ≤7 days any 100 mg/kg/dose IV/IM q8 h (equivalent to 300 mg/kg/day)
≥8 any 75 mg/kg/dose IV q6 h (approx. 300 mg/kg/day)
PICU, cardiac ICU ≤29 days ≥8 100 mg/kg/dose IV q8 h up to a max single dose of 1 g
Any 100 mg/kg/dose IV q8h
Meningitis or
osteomyelitis
General care ≥14 yrs < 27 75 mg/kg/dose IV q6h
≥27 2 g IV q6h
Non-pediatric location ≤7 days ≥9 100 mg/kg/dose IV q8 h up to a max single dose of 1 g
< 9 100 mg/kg/dose IV q8h
8 days-14
yrs
< 27 75 mg/kg/dose IV q6h
≥27 2 g IV q6h
14-18 yrs ≥27 & <45 2 g IV q6h
< 27 75 mg/kg/dose IV
q6h
Pediatric liver
transplant - post-op
Any location - dosing region
scenarios defined by order
set use
≥0 days < 20 50 mg/kg q6 h × 4 doses
≥20 1 g q6 h × 4 doses
Pediatric liver
transplant - pre-op
Any location - dosing region
scenarios defined by order
set use
≥0 days < 20 50 mg/kg ONCALLPRN* to OR
≥20 1 g ONCALLPRN* to OR
*The dose is administered once a patient is called to the operating room.
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pocket cards that give dosing suggestions for commonly
used medications in their care areas. If these medica-
tions were located on the card, then they were required
to undergo dosing region development. The full drug
list was then grouped by American Hospital Formulary
Service (AHFS) drug class and prioritized for dosing
region development.
Pediatric dosing references [27-29], literature review,
and insight from at least 2 clinical pharmacists serving
o nt h eA D Mt a s kf o r c ew e r eu s e dt od e f i n ed o s i n g
regions. Once all dosing regions were designed, a final
review was conducted by a sub-specialty physician. By
1 month after ADM deployment, 1200 dosing regions
were built for 175 medications. As of July 2009, the
knowledge base had expanded to include over 2300 dos-
ing regions for 375 medications. Dosing regions are
reviewed and updated based on new clinical evidence
once every 2 years.
Because dosing is often based on weights and involves
calculation, it was important to create logic that facili-
tates prescribing drugs in practical amounts. To this
end, each dosing region was assigned a rounding
method by linkage to a specific data table within the
ADM database schema that defined a type of rounding
behavior. The “round to 10%” data table lists dosing
values where the dispensable dose should be rounded to
the closest value in the table, which would ultimately be
within 10% of the weight-based calculation. If a calcu-
lated dose falls outside of the values in the table, no
rounding should occur. A second “round to 5%” data
table functions similarly and was put into place for dos-
ing regions requiring tighter control such as those for
narcotics, sedatives, and steroids. Finally, specialized
rounding tables were created on a drug-by-drug basis to
allow for cases where high customization is necessary.
For example, several suppository rounding tables were
created to reflect commonly dispensable partial supposi-
tory amounts for children. The creation of these tables
had the effect of forcing selection of drugs in an easily
dispensable form.
Designation of patient parameters describing dosing
regions
Each dosing region specifies appropriate dosing advice
within the context of 6 patient-specific parameters
(Table 2). These parameters were defined by the clinical
advisory workgroup discussed previously. One of the
more complex issues addressed was patient weight, and
it became clear that multiple weights would be required
for the system to be clinically relevant to pediatric
patients. The concept of “dosing weight” was made dis-
tinct from “actual weight” to account for excesses or
deficiencies in weight due to fluid imbalances, infections,
or feeding issues. Thus dosing weight is the weight on
which dosing recommendations should be based, and
the clinician should actively decide whether the actual
weight is appropriate or a dosing weight should be
entered to reflect either transient physiologic changes,
such as excess body water, or chronic conditions such
as pediatric obesity.
When considering the matter of age for medication
dosing, the ADM was designed to provide unit transla-
tion for the clinician. In older children, it is appropriate
to classify chronological age in whole-number years
(e.g., 8 years rather than 8.25 years); however, infants
may have age stored in months (or days for newborns).
Depending on the age of the child, the ADM may
prompt the clinician for gestational age if needed to
identify the correct dosing region for a medication.
Renal impairment was included as a potential dosing
parameter based upon a qualitative assessment by the
ordering provider (i.e., “impaired” or “not impaired”),
which is requested when nephrotoxic drugs are dosed.
This assessment will result in a suggestion of a different
dosage of the drug. Including this as part of the dosing
region parameters serves as an important reminder to
the ordering provider that the drug is either renally
cleared or builds up metabolites and therefore requires
consideration of dose adjustment.
The ADM dosing region selection process may require
knowledge of a patient’s indication. If so, a provider is
prompted to select an indication within the CPOE cli-
ent. Common indication-based dose adjustments include
those used in cases of meningitis, osteomyelitis, or an
infectious disease. A second pathway to dosing by indi-
cation is to use an indication-specific order set for spe-
cialized dosing in support of unique disease states or
clinical conditions such as sickle cell anemia, cystic
fibrosis, or organ transplant dosing. The ADM automa-
tically understands the patient indication based on the
order set identity and presents the user with the appro-
priate, specific spectrum of dosing regions. The user
may be prompted further if additional indications are
needed to define the dosing region.
Error prevention measures
When a single CPOE system is used for both children
a n da d u l t s ,t h es y s t e mm u s td i f f e r e n t i a t eb e t w e e nt h e2
populations so that it knows when to implement the
correct logic. It was recognized early in the planning
process that most of the safety features of pediatric
C P O Ew o u l db eu n d e r m i n e di ft h ew r o n gw e i g h ti s
entered for the patient. Pediatric patients tend to
undergo changes in weight more often and to a larger
degree than adults, and each manual update of that
changing weight is an opportunity for error. To address
this, the ADM was configured with several weight-based
Ferranti et al. BMC Medical Informatics and Decision Making 2011, 11:14
http://www.biomedcentral.com/1472-6947/11/14
Page 5 of 12“pop-up” alerts:
￿ The user cannot enter any medication without
being prompted for a dosing weight if one is not
already present. Patient weights are compared to
either pediatric or neonatal growth curves stored
w i t h i nt h eC P O EO r a c l ed a t a b a s ec l i n i c a lc o n t e n t
tables. Users are warned if a patient falls below 3rd
percentile or above 97th percentile.
￿ The user is alerted if there is an extreme change in
weight–on average, a change in 10% of the pre-
viously recorded value. This threshold is configur-
able by care area.
￿ The user is warned if there is an extreme variance
between actual and dosing weight, and the variance
threshold is configurable by care area.
￿ If a medication order was dosed off a weight that
had since been updated, a reminder to “weight
adjust” the medication dose is issued.
￿ Any patient parameter that is expected to change
over time (i.e., dosing weight or actual weight) will
raise a less invasive alert (colorful text-based tag
next to the variable in question) if it has not been
updated after a configurable number of days. It is
our expectation that actual weights are updated
daily, and dosing weights are updated based on the
unit protocol and clinical condition.
Because the pediatric CPOE system was based on a
prior adult implementation, adult-specific decision sup-
port is left embedded in medication orderables through-
out the system. Most orderables contain, for example,
adult options for dose, route, frequency, etc., along with
instructional text describing appropriate dose recom-
mendations and other considerations specific to that
drug. We recognized that it was critically important that
pediatricians not be inadvertently presented with adult
dosing advice and therefore used a 2-pronged strategy
(suppression and redirection) for handling adult-
oriented material that may be presented to the end user.
Suppression functionality was implemented for cases
where pediatric dosing regions are not available for certain
medications but adult-based material is available in the
clinical content tables. Any dosing guidance present in the
base form of the medication–which is assumed not to
have been approved for use in pediatrics–is suppressed in
the CPOE application code whenever the patient fits our
definition of “pediatric.” A countermeasure (i.e., a way to
“suppress the suppression”) was implemented for unique
clinical situations where the same dosing principles apply
regardless of whether CPOE considers the patient “pedia-
tric” or “adult.” The obstetrics service, for example, uses
the same labor-and-delivery order sets whether their
patient is 12 or 32 years old. Such order sets are
designated safe for use in both adults and pediatric popu-
lations and thus exempt from the suppressive logic.
Redirection functionality was implemented for cases
where it is appropriate for the pediatric prescriber to
completely avoid selection of a particular drug. Insulin
prescribing, for example, is a complicated endeavor that
involves multiple drug orderables because it requires
options for different forms of scheduled and supplemen-
tal insulin. Clinicians caring for adult patients have
always had a full-page, graphical module (“Subcutaneous
Insulin Advisor”) that presents formal decision support.
When the analogous pediatric interface was created, we
recognized the risk of a pediatric clinician inadvertently
activating the adult-oriented insulin advisor (e.g., with a
misdirected mouse-click). Th e r e f o r e ,w ec r e a t e dal o g i c
module, triggered by the user’s selection of the adult
insulin advisor, that determines whether the patient
meets the definition of “pediatric” and, if so, redirects
the user to the pediatric version.
Analysis of voluntarily reported safety events
The voluntary Safety Reporting System (SRS) allows
staff members to report any perceived safety issues
within any DUH care environment, including DCH.
DCH staff enters approximately 80 pediatric reports per
month. Incidents are reported as being 1 of 9 event
categories, and all incidents in the medications category
are reviewed by a team of medication safety pharmacists
and scored for patient severity. Events of severity of 3 or
more (i.e., patient length of stay was increased by the
event) are considered ADEs. A full description of the
severity algorithm is reported elsewhere [24]. We com-
pared the rate of harmful events (i.e., ADEs) per 1000
patient days and the fraction of total reported events
that were ADEs pre- and post- deployment for critical
care areas. The Pearson’s chi-square test was used to
assess statistical significance, and binomial 95% confi-
dence intervals for proportions were calculated.
Results and Discussion
Clinician workflow for medication ordering within the
CPOE interface
Users enter the CPOE interface through the organiza-
tional electronic health record. The process of ordering
medications using CPOE can be initiated by either
searching for them using a dialog box within the appli-
cation or choosing an order set developed for a specific
patient profile and then clicking on the hyperlink for an
ADM-enabled medication. When a patient is admitted
to DCH, details regarding the patient’s identity, age, and
current physical location are transmitted to the CPOE
application from the hospital’s admission, discharge, and
transfer system. The ADM uses this information, along
with prompted provider input and its underlying clinical
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tion dosing logic is required (Figure 1).
Once within the ADM logic, the top half of the screen
will display all patient parameters and any relevant con-
siderations or warnings for the drug. The bottom half
displays actions to be taken. If an allergy to a medica-
tion is known, warnings will be shown at this step, and
the user must override the allergy alert twice in the bot-
tom half of the screen before being permitted to move
forward with medication ordering. If there are no warn-
ings, the ADM will prompt for any additional informa-
tion (i.e., indication) and presents the proper dose/
frequency combinations determined by the patient para-
meters. For example, when ampicillin is chosen, the sys-
tem automatically narrows down the available dosing
regions based on the patient’s age, weight, and care
intensity as defined by location. Because ampicillin dos-
ing regions differ based on indication, it asks the user
for this information (e.g., meningitis), and then the sys-
tem provides the user with appropriate dosing guidance
and automatically displays the correct dose and interval
to be ordered (Figure 2). During this process, the ADM
has calculated dosage based on weight, applied custom
numeric rounding, and enforced maximum and mini-
mum doses. Unlike other CPOE applications that pre-
sent all possible choices of ordering combinations, our
application uses the ADM to display a limited subset of
recommendations that only includes options deemed
appropriate for the patient in question. This greatly
reduces display “noise” associated with long lists and
helps prevent potential errors due to incorrect selection.
The user can either select this dosing region or manu-
ally enter the dosage desired (i.e., an override). From
this point, the user will be taken through a series of
screens where he or she may enter dose form, start
time, duration, and any additional comments for the
pharmacy department that are stored in a text field. The
last screen will show a summary of the order and all
selections made, at which point the user may accept,
save as a draft, modify, or exit without saving or order-
ing. After this terminal step, the order is electronically
routed to the pharmacy department for processing. If
dosing regions are undefined or do not fit the patient-
specific criteria, the system will exit the ADM and
prompt the user to manually enter the desired medica-
tion order–similar to the process that routinely occurred
on paper prior to CPOE deployment.
Guarding against over- and under-dosing
In allowing providers to override the dosing region logic,
it became clear during the testing phase that there is
potential for a provider to mistype the dose and order far
too much or too little drug. As a result, we programmed
extra safeguards into the dosing region knowledge base
by having the ADM alert the user if a value is entered
that exceeds the minimal or maximal drug doses per-
mitted by any dosing region associated with that medica-
tion. To override this, the user must enter the exact
“aberrant” value a second time before the ordering pro-
cess will move forward. We chose this route as opposed
to requiring that the user enter a reason for the override
to guard against cases where an override is justified and
yet an unintentional, excessively extreme dosage is still
entered. We believe this level of active participation by
the user (as opposed to the oft-used passive alerting; e.g.,
having to click an “OK” button) strikes a reasonable bal-
ance in preventing errors with minimal annoyance. In
every case within the CPOE application where alerting
methods were used, we recognized that over-alerting
(such that the warnings no longer command the user’s
attention) is as ineffective as no warnings at all and
attempted to set alert thresholds accordingly.
Limited evaluation of CPOE implementation using
organizational safety data
Given the extensive literature available that discusses the
impact that CPOE may have in terms of unintended
patient harm in critical care areas [12,13,15,18,19], we
felt compelled to evaluate our intervention using avail-
able safety and quality resources. We examined data
from our organizational voluntary Safety Reporting Sys-
tem (SRS) to ask whether the rates of adverse drug
events increased in pediatric critical care after CPOE
deployment. Full details regarding the SRS system have
been thoroughly described previously [24,25]. We
acknowledge that relying solely upon voluntarily
reported events may be problematic due to the well-
known issues of reporting bias, volume, seasonality, and
anonymity concerns [30]. However, voluntary reporting
data have been used elsewhere to evaluate pediatric
CPOE systems to better understand the effects of the
implementation when a more rigorous prospective study
is not possible [12]. Furthermore, SRS is well established
within our health system and has become an integral
part of the culture of safety at Duke Medicine.
With these caveats in mind, we collected all reported
harmful ADEs (i.e., at the minimum, transient adverse
p a t i e n te f f e c t so c c u r r e dt h a tr e q u i r e ds o m ec o r r e c t i v e
therapy or increased length of stay) [24,25]. The ADE rate
decreased 42.9% (p = 0.012) and 46.4% (p = 0.006) in
the PICU and NICU units, respectively. Similarly, the per-
centage of total reports that were severe ADEs decreased
significantly in each unit (Table 4). We cannot rule out
the effects of reporter bias, and event volume is too low to
look at the reports in terms of categories of system failures
and attributable causes. Pediatrician review of the event
narratives entered by the medication safety pharmacists
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Page 7 of 12Figure 1 Processing logic of the Advanced Dosing Model. A clinician initiates an order for a medication. ADM pre-processing logic verifies if
dosing regions exist for this drug. If so, the system will retrieve the available patient information (chronological age, weight, and care area) and
prompt the user for any additional information needed. Once all patient parameters are collected, the decision support algorithm will resolve
the list of all potential dosing regions from the clinical knowledge base. If the algorithm successfully identifies 1 dosing region, it is presented to
the clinician and made available for calculations and screening. If there are no dosing regions available for the requested medication and patient
parameters, or multiple dosing regions are found, the system exits the ADM model and the clinician is prompted to enter a medication dose
manually.
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Page 8 of 12suggests that there may be fewer PICU reports within 2
primary areas of acknowledged weakness in medication
processing–incorrect ordering and order transcription–
although the data are sparse. Although we were unable to
prospectively study the impact of the advanced dosing
model on patient safety, this retrospective analysis of
v o l u n t a r i l yr e p o r t e ds a f e t yd a t as u g g e s t st h a tw eh a v e
improved the safety of medication dosing in our pediatric
critical care population.
Comparison to other pediatric dosing models
A comprehensive comparison to other systems is ham-
pered by the lack of rigorous reports on CPOE dosing
rule development in the formal literature. Commercial
CPOE systems, including Horizon Expert Orders, often
use formulary references such as First Databank [31] or
Lexicon-Multum [32] for static dosing advice (e.g., drug-
drug interactions or allergy alerts) but not for active dos-
ing assistance or management of the dosing process
where tailored doses are suggested based on the patient’s
clinical profile. Although true clinical decision support
knowledge bases are available, these are focused on
adults, require much manipulation for use in the hospital
setting, and are underdeveloped for pediatrics [33].
WizOrder, the predecessor of our CPOE system, did
evolve to include weight-based dosing [26], but the lack
of a full report that describes its implementation is a
barrier to comparative analysis. In a 1-page conference
proceeding, the authors include the concept of dosing
weight, as well as a process by which existing orders are
reviewed when the patient’s weight changes significantly.
Our weight-based dosing also includes checking against
growth curves to ensure that the change in weight from
the prior value is logical. When 1 new drug is dosed on
an updated weight, the other drug orders live on a
patient are automatically checked to see if the dosing
region is still appropriate or should be updated.
Figure 2 Screenshot of pediatric medication dosing. This screenshot shows the presentation of an ampicillin dosing region for an infant at
Duke Children’s Hospital. The left panel displays the current orders for the patient. The right top panel presents the recommended dosing
region based on the patient’s dosing weight, age, physical location, and indication. The provider may click and select the suggested value
(50 mg/kg) or enter his or her own dosage manually as an override.
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Page 9 of 12Killelea and colleagues published a description of their
pediatric dosing decision support rules for a large teach-
ing hospital [34]. Like our ADM, their method included
designing rules by committee based on medication, age,
and weight. However, they do not go into much detail
regarding how the weights are managed, nor do they
describe alerting functionality surrounding weight as we
have at DCH. Additionally, their consideration of indica-
tion is limited to displaying the dosing guidance for the
default indication and providing pop-up windows that
describe dosing rules for other less common indications.
Patient-specific indication details are not considered by
the system, and location-based customization (i.e., care
intensity) is not included for presenting a dosing sugges-
tion. Rounding is configurable on a per-medication rule
level, but their system as reported is not configurable
per location as is the case at DCH.
Our incorporation of location thus comes into focus
as an important, novel aspect of our model. We use
location as a critical identifier of care intensity, which is
especially important given our large BMT and ICU
population. These patients often receive augmented
doses of medications given the severity of their illness–
doses that may be severely harmful to other pediatric
patients. It is therefore critical that the decision support
inherent to the dosing regions “locks” this content to
only the BMT and ICU units. Similarly, cystic fibrosis
patients have equally unique medication needs, and so
the inclusion of an indication parameter in the ADM
allows us to focus clinical content just to this specialized
population. Overall, the modular nature of the dosing
region model allows us to easily develop new dosing
scenarios for specialized populations, especially if the
pediatric population profile at DCH changes over time.
Limitations and lessons learned
The ADM represents a unique, modular approach to
manage the logistics of adding increasingly complex
clinical decision support information to an existing
CPOE application. This allowed us to tailor the adult
tool to the unique needs of pediatrics. However, in prac-
tice, there are practical and clinical considerations
regarding whether a subpopulation warrants specialized
dosing using an ADM approach. There can be signi-
ficant resource management, implementation, and
maintenance trade-offs between over-defining and under-
defining patient subpopulations. Thus, a core limitation
with the dosing region model of medication ordering is
that it is not practical to develop a dosing region for
every conceivable scenario of pediatric drug dosing. As a
result, there will always be certain medications without
any dosing regions or instances of dosing region gaps
where the ADM is unable to suggest an appropriate
dose. Use of dosing regions, therefore, requires that end
user clinicians resolve these gaps. In all cases where the
ADM is not able to suggest unique dosing, the patient
parameters, medications involved, and manually entered
dosages are recorded in an audit file for further review to
determine if systematic needs are being unmet.
Addressing patient weight in the provider work flow
Because the ADM relies so heavily on patient weight in
pediatric dosing, it became critically important to study
the workflow processes that shape how a provider inter-
prets the definition of weight in order to guard against
unexpected results. Potential for unintended conse-
quences is significant in a culture that thinks in pounds
but doses in kilograms, which would translate into
greater than double the intended dose of medication.
Providing alerts to address both extremes of the possible
weight continuum addresses this issue but has its own
challenges. DCH has a large patient population with dis-
ease states or chronic conditions that often result in
cases of extremely low weight due to poor growth. Even
among the general care areas, the increasing prevalence
of obese children requires frequent adjustments to com-
monly accepted dosing paradigms. As a result, crafting
alerts that would remind the provider and still avoid
alert fatigue was extremely important. Once a patient’s
weight was entered in the CPOE application, it soon
became necessary to define policies surrounding weight
definition and responsibilities for its updating during the
course of a patient’s stay. Although nurses updated the
Table 4 Voluntarily reported adverse drug events pre-
and post-deployment of the pediatric Advanced Dosing
Model
Unit Pre-ADM Post-ADM
PICU
No. events 421 410
No. ADEs 53 31
% ADEs (CI) 12.6 (9.4-15.8) 7.5 (5.0-10.1)
% change (p value) -39.9 (0.016*)
No. patient days 14,027 14,370
ADEs per 1000 patient days (CI) 3.8 (2.8-4.8) 2.2 (1.4-3.0)
% change (p value) -42.9 (0.012*)
NICU
No. events 567 272
No. ADEs 75 23
% ADEs (CI) 13.2 (10.4-16.0) 8.5 (5.2-11.8)
% change (p value) -36.1 (0.044*)
No. patient days 45,627 26,122
ADEs per 1000 patient days (CI) 1.6 (1.2-2.0) 0.9 (0.5-1.3)
% change (p value) -46.4 (0.006*)
Pre-period begins on 9/17/2004 and ends the day before the CPOE
deployment dates for each unit described in Table 1. Post-period begins the
day of CPOE deployment and ends 12/31/2009. CI = confidence interval.
*Significant by 2-way Pearson’s chi-square test.
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Page 10 of 12actual weight in their stand-alone documentation sys-
tem, it was important that this weight was simulta-
neously updated in the CPOE system. Because of the
impact of weight on medication dosing, it was decided
that only physicians or physician extenders could enter
or update this value.
Overreliance on technology
O n eu n e x p e c t e ds i d ee f f e c to ft h ed o s i n gr e g i o nm o d e l
was that providers quickly became accustomed to the con-
cept and were concerned when no dosing region was pre-
sent. Frontline users expected the computer to prevent
any bad decisions, and yet, the clinical advisory committee
was reluctant to make any restriction on dosing regions
that would compromise a provider’s flexibility in ordering.
Providers had to be educated to think critically about the
dosing recommendations for each patient, and were
reminded that the thought process in manually entering a
dosage drug without a dosing region within CPOE is
nearly identical to the prior paper-based ordering process.
The importance of team composition
Finally, computerized decision support design is not a
typical knowledge area for most clinical practitioners,
and, conversely, IT system developers often do not pos-
sess an understanding of the dynamic health care envir-
onment in which their applications are used. Because
CPOE is technically sophisticated with immense clinical
impact, it is extremely important that the design team
include individuals who can bridge the traditional IT
and clinical specialty divide. Such individuals review
functional and technical specifications with an eye for
clinical impact, potential functionality conflicts, and
knowledge base gaps.
Conclusion
In this study, we describe the implementation of a
pediatric Advanced Dosing Model that acts as an
enhancement to an adult-centric, vended CPOE system
in order to meet the unique challenges of pediatric care.
Despite some limitations, the ADM provides a powerful
way to guide pediatricians through the medication
ordering process. The model uses knowledge of the
patient’s state to deliberate on care parameters and sug-
gest the appropriate dose.
Enhancing an adult-focused CPOE system for safe
pediatric medication management is a daunting task.
When undertaking such a project, it is essential that
physicians and pharmacists with formal informatics
training serve as an interface between the clinicians and
the development team. We hope that the strategies
described here will serve to guide other pediatric institu-
tions as they develop their own plans for the implemen-
tation of pediatric computerized provider order entry.
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